Stockscreener 앱 받기
18.57
0.85%
-0.16
시간 외 거래:
18.57
전일 마감가:
$18.73
열려 있는:
$18.6
하루 거래량:
242.79K
Relative Volume:
0.76
시가총액:
$640.45M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-5.50%
1개월 성능:
+10.47%
6개월 성능:
-28.25%
1년 성능:
+0.00%
1일 변동 폭
$18.30
$18.84
1주일 범위
$18.30
$19.69
52주 변동 폭
$10.01
$32.75
Ceribell Inc Stock (CBLL) Company Profile
명칭
Ceribell Inc
전화
(800) 436-0826
주소
360 N. PASTORIA AVENUE, SUNNYVALE
CBLL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
18.57 | 640.45M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
136.26 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.78 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.74 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.75 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.18 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-04 | 개시 | Ladenburg Thalmann | Buy |
| 2024-11-05 | 개시 | BofA Securities | Buy |
| 2024-11-05 | 개시 | Canaccord Genuity | Buy |
| 2024-11-05 | 개시 | JP Morgan | Overweight |
| 2024-11-05 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 개시 | William Blair | Outperform |
모두보기
Ceribell Inc 주식(CBLL)의 최신 뉴스
CeriBell, Inc. (NASDAQ:CBLL) Given Average Rating of “Buy” by Brokerages - Defense World
Ceribell, Inc. Announces Results of Annual Meeting - MSN
CeriBell: An EEG Concern Posting Impressive Growth (NASDAQ:CBLL) - Seeking Alpha
Ceribell shareholders approve board nominees and auditor By Investing.com - Investing.com South Africa
Ceribell shareholders approve board nominees and auditor - Investing.com
Bank of America Corp DE Invests $498,000 in CeriBell (NASDAQ:CBLL) - Defense World
Nuveen Asset Management LLC Makes New Investment in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell CEO Chao Xingjuan sells $425,000 in stock By Investing.com - Investing.com Nigeria
Ceribell CEO Chao Xingjuan sells $425,000 in stock - Investing.com
Ameriprise Financial Inc. Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
BNP Paribas Financial Markets Invests $43,000 in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc.: Strategic Growth and Profitability Amidst Market Challenges - TipRanks
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys Shares of 6,957 CeriBell (NASDAQ:CBLL) - Defense World
The medtech IPO window is finally open. Or is it? - MedTech Dive
CeriBell (NASDAQ:CBLL) Receives $32.50 Average Price Target from Brokerages - Defense World
Northern Trust Corp Invests $2.66 Million in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc.: Strong Q1 Performance and Promising Growth Justify Buy Rating - TipRanks
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference - GlobeNewswire
Ceribell CEO Chao Xingjuan sells $424,000 in stock - Investing.com Australia
Ceribell CEO Chao Xingjuan sells $424,000 in stock By Investing.com - Investing.com South Africa
Tower Research Capital LLC TRC Takes $37,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell stock holds $36 target amid US-China trade deal hopes - Investing.com Canada
Ceribell stock holds $36 target amid US-China trade deal hopes By Investing.com - Investing.com South Africa
US$30.75: That's What Analysts Think CeriBell, Inc. (NASDAQ:CBLL) Is Worth After Its Latest Results - Yahoo Finance
Wells Fargo & Company MN Takes $167,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc. Earnings Call Highlights Growth and Challenges - TipRanks
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older - The Globe and Mail
AI in Clinics and Hospitals, Along with FDA Steps Signal Opportunity for Early Mover Advantages - The Globe and Mail
Earnings call transcript: CeriBell Q1 2025 revenue jumps, stock rises 6.81% - Investing.com Nigeria
Ceribell, Inc.: A Strong Buy Amidst Promising Growth and Robust Fundamentals - TipRanks
CeriBell revenue jumps 42% to USD 20.5 million in Q1 2025 - Medical Buyer
MetLife Investment Management LLC Acquires Shares of 7,749 CeriBell (NASDAQ:CBLL) - Defense World
Barclays PLC Makes New Investment in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc. Reports Strong Q1 2025 Growth - TipRanks
Ceribell, Inc. Receives Buy Rating Amid Strong Revenue Growth and Financial Performance - TipRanks
CeriBell Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: CeriBell Q1 2025 revenue jumps, stock rises 6.81% By Investing.com - Investing.com South Africa
Ceribell reports Q1 EPS (36c), consensus (46c) - TipRanks
Ceribell Reports First Quarter 2025 Financial Results - GlobeNewswire
CeriBell Inc expected to post a loss of 42 cents a shareEarnings Preview - TradingView
Invesco Ltd. Takes $252,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell Inc (CBLL) 재무 분석
Ceribell Inc (CBLL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Ceribell Inc 주식 (CBLL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ROBERTSON REBECCA B | Director |
Jun 17 '25 |
Sale |
17.63 |
7,445 |
131,255 |
21,230 |
4.52%
0.92%
자본화:
|
볼륨(24시간):